- 更多网络例句与专利药品相关的网络例句 [注：此内容来源于网络，仅供参考]
-
In May it said it was entering licensing deals with Claris LifeSciences and Aurobindo, both Indian generics firms.
今年5月，该公司与印度的两家非专利药品制造商Claris Lifesciences与Auro-bindo达成经销权协议。
-
The most striking deals have involved Pfizer, a conservative giant not known for cosiness with upstart generics firms. In May it said it was entering licensing deals with Claris LifeSciences and Aurobindo, both Indian generics firms.
最劲爆的消息是关于Pfizer的，这个保守的制药公司一直对抢手的非专利药品不感什么兴趣，但在5月它却宣布正在与印度的两大非专利药品公司Claris LifeSciences和Aurobindo进行关于许可经营的磋商。
-
Therefore, the United States will be encouraged to use some generic drugs because the patent medicine prices higher.
因此，美国将鼓励使用仿制药，因为某些专利药品价格上涨。
-
In effect, the industry was selling dangerous patent medicine to gullible consumers.
事实上，这个产业把危险的专利药品卖给容易上当的消费者。
-
According to the plan, we will produce two more thousand kilos of this patent medicine next moth.
按照计划，下个月我们要再多生产两千克这种专利药品。
-
Under the Protocol, in the event of public health emergencies such as AIDS, malaria, phthisis and other epidemics, developing and least developed members may invoke patent compulsory license system, allowing making, using, selling or importing patented drugs from other eligible members for the treatment of the above diseases.
根据议定书，发展中成员和最不发达成员可以在国内因艾滋病、疟疾、肺结核和其他流行病而发生公共健康危机时，在未经专利权人许可的情况下，在国内实施专利强制许可制度，生产、使用、销售或从其他实施强制许可制度的成员进口有关治疗上述疾病的专利药品。
-
Jeff George, head of Sandoz, a large generics firm owned by Novartis, a Swiss drugmaker, is convinced that the lure of those growing markets is unleashing an "entirely new dynamic".
Sandoz是瑞士制药商Novartis旗下的一所大型非专利药品生产公司，其总经理Jeff George深信，这些正处上升态势的药品市场正释放出一股全新的活力。
-
The latter three strategies are new and also the paper's three innovative points. First of all, appeal the law to prohibit reversed payment, unify this with the BOLAR exception, and promote the drugs into the market as soon as possible. Secondly, put the public health, medicine patent and the IPRs protection of traditional knowledge and the genetic resources together. Through giving the traditional knowledge and the genetic resources IPRs protection to treat the developed countries' medicine patents, they can settle the public health crisis. Finally, the legal mechanism of Prior Consent is a new strategy that Brazil proposed for the purpose of protecting the public health, which divides the examination of patent applications for pharmaceutical products and processes between two federal agencies, National Institute of Intellectual Property and National Sanitary Supervision Agency. ANVISA has the obligation to render the final decision, granting or denying a patent.
其中前四种措施是国际社会上一直以来倡导的主要措施，后三种是新的解决公共健康危机的法律措施，其创新点在于：第一，呼吁将禁止反向支付纳入法律，并与BOLAR例外相结合使用，促进仿制药品的尽快上市；第二，将公共健康、医药品专利以及传统知识和遗传资源的知识产权保护三者紧密相连，通过对传统知识和遗传资源予以知识产权保护来应对发达国家的医药品专利；第三，&事先同意&法律制度是巴西提出的一种旨在保护公共健康，应对医药专利的新的法律制度，该制度规定凡是涉及医药品专利的申请都必须经过国家知识产权局和国家公共卫生监督局的公共审查，并且国家公共卫生监督局有是否授予专利的最终决定权。
-
Pfizer's David Simmons even says that "generics are not the enemy of innovative pharma any longer". Rather, he insists, firms once derided as copycats and scofflaws should be seen as essential allies in entering new markets.
辉瑞制药公司的大卫-西蒙斯声称，非专利药品不再是创新型药企的对头，而且，他还表示，在打入新市场的过程中，就应当把那些过去曾经因仿造等违规行为受讥讽的制药公司视为重要的合作者。
-
From Japan to Germany, governments are liberalising drug markets, sweeping away barriers to generics.
从日本到德国，国家政府都在放宽药品市场，为非专利药品的发展扫清障碍。
- 更多网络解释与专利药品相关的网络解释 [注：此内容来源于网络，仅供参考]
-
Bristol-Myers Squibb：百时美施贵宝公司
其中包括业界巨头百时美施贵宝公司(Bristol Myers Squibb)和默克公司(Merck & Co),它们都因主导药品失去专利保护而受到了仿制药的打击. 绝大部分股东还批准了与此相关的两项方案. 其一,辉瑞要求大部分股东投票支持为合并而发行普通股的计划.
-
ethical：伦理
与上述那些卖没有专利的所谓"专利药"的药商不同,在当时这些药店主要业务是生产出高质量的药品提供给医生,这些药品当时被称为"伦理药品"(ethicalpharmaceuticals),"伦理"(ethical)这里的意思是说药品的质量可靠和药商的"诚实"(honest),
-
Mail Box：信箱
1995年1月1日尚未给予药品与农业化学产品专利保护的,都应给予所谓"邮政信箱"(mail box)的行政保护,即,第一,在过渡期内提供此类发明的专利申请的方法;第二,授予该申请专利的产品以5年独占市场销售权或直至该申请获准或被拒绝,
-
Mailbox：信箱
这通常被称为"信箱"(mailbox)制度. 这不仅与日后专利审查的新颖性有关,而且还与药品和农业化学品的行政保护有关. 印度在世界贸易组织成立之时没有提供对于药品和农业化学品的产品专利保护,应当提供"信箱"保护.
-
Mailbox：邮箱
印度提出,作为一个对相关技术领域不提供专利保护的发展中国家成员,其目前依照本款所承担的义务限于建立一个"邮箱"(Mailbox),以接受和保存对药品及农用化学品的专利申请,并根据本款的其他规定适当地授予申请日和优先权日.
-
patent medicine：专利药品,成药
patent marking 专利标记,专利权的标示 | patent medicine 专利药品,成药 | patent mitcheline 提花缎
-
patent medicine：专利药品
专利商标品/proprietary name;proprietary term | 专利药品/patent medicine | 专题节目/feature programme
-
Patent medicine scandals：专利药品丑闻
1980年和USP合并 Combined with USP in 1980 | 专利药品丑闻Patent medicine scandals | Problem 问题
-
pharmaceutical patents：药品专利
药物分析:Pharmaceutical assay | 药品专利:pharmaceutical patents | 药品专利:pharmaceutical patent
-
trade name：商品名
药品的商品名(Trade Name)一般是指药品生产商对其生产的药品命名的,并向政府主管部门注册的药品名称. 在国外,药品的商品名主要是用于自己研发的具有自主知识产权的产品. 由于新药专利保护是有期限的,而商品名是永久独占的,有鉴于此,